CVRx Market Capitalization from 2010 to 2025
| CVRX Stock | USD 12.33 0.27 2.14% |
Check CVRx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CVRx's main balance sheet or income statement drivers, such as Tax Provision of 100.7 K, Depreciation And Amortization of 650 K or Interest Expense of 2.3 M, as well as many indicators such as Price To Sales Ratio of 8.3, Dividend Yield of 0.0 or PTB Ratio of 2.36. CVRx financial statements analysis is a perfect complement when working with CVRx Valuation or Volatility modules.
CVRx | Market Capitalization |
Latest CVRx's Market Capitalization Growth Pattern
Below is the plot of the Market Cap of CVRx Inc over the last few years. It is CVRx's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CVRx's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 328.05 M | 10 Years Trend |
|
Market Cap |
| Timeline |
CVRx Market Capitalization Regression Statistics
| Arithmetic Mean | 262,841,132 | |
| Geometric Mean | 261,409,862 | |
| Coefficient Of Variation | 11.98 | |
| Mean Deviation | 17,118,807 | |
| Median | 253,406,945 | |
| Standard Deviation | 31,486,673 | |
| Sample Variance | 991.4T | |
| Range | 132.1M | |
| R-Value | 0.31 | |
| Mean Square Error | 961.3T | |
| R-Squared | 0.1 | |
| Significance | 0.25 | |
| Slope | 2,039,045 | |
| Total Sum of Squares | 14871.2T |
CVRx Market Capitalization History
About CVRx Financial Statements
CVRx investors use historical fundamental indicators, such as CVRx's Market Capitalization, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in CVRx. Please read more on our technical analysis and fundamental analysis pages.
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. CVRx, Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota. Cvrx operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 109 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Additional Tools for CVRx Stock Analysis
When running CVRx's price analysis, check to measure CVRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CVRx is operating at the current time. Most of CVRx's value examination focuses on studying past and present price action to predict the probability of CVRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CVRx's price. Additionally, you may evaluate how the addition of CVRx to your portfolios can decrease your overall portfolio volatility.